GIAMMARUCO, MARISTELLA
GIAMMARUCO, MARISTELLA
Mostra
prodotti
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.004 secondi).
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors
2021 Marinelli, D.; Pisegna, S.; Giammaruco, M.; Chesi, P.; Mammone, G.; Ceddia, S.; Gazzaniga, P.; Cortesi, E.; Gelibter, A. J.
Evaluation of drug-drug interactions in EGFR-mutated non-small-cell lung cancer patients during treatment with tyrosine-kinase inhibitors
2021 Occhipinti, M; Brambilla, M; Galli, G; Manglaviti, S; Giammaruco, M; Prelaj, A; Ferrara, R; De Toma, A; Proto, C; Beninato, T; Zattarin, E; Lo Russo, G; Gelibter, Aj; Simmaco, M; Preissner, R; Garassino, Mc; De Braud, F; Marchetti, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors | 2021 | Marinelli, D.; Pisegna, S.; Giammaruco, M.; Chesi, P.; Mammone, G.; Ceddia, S.; Gazzaniga, P.; Cortesi, E.; Gelibter, A. J. | |
Evaluation of drug-drug interactions in EGFR-mutated non-small-cell lung cancer patients during treatment with tyrosine-kinase inhibitors | 2021 | Occhipinti, M; Brambilla, M; Galli, G; Manglaviti, S; Giammaruco, M; Prelaj, A; Ferrara, R; De Toma, A; Proto, C; Beninato, T; Zattarin, E; Lo Russo, G; Gelibter, Aj; Simmaco, M; Preissner, R; Garassino, Mc; De Braud, F; Marchetti, P |